← Leaderboards
Jhanelle E. Gray
H. Lee Moffitt Cancer Ctr & Res Inst
$250,326
Attributed
$501,746
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $441.7K · FY2020–21$500K$375K$250K$125K$0
'20
'21
Funding mix
By agency
NIH$501,746 · 2
By mechanism
R01$377,130 · 1
P30$124,616 · 1
Top collaborators
- Jeffrey Melson Clarke1 shared
- Jennifer Ann Freedman1 shared
Most similar at H. Lee Moffitt Cancer Ctr & Res Inst
Same institution · by research overlap
- John M Koomen$3,679,194
- Derek Ronald Duckett$9,922,620
- Eric B. Haura$11,744,471
- Thomas D Bannister$24,896,252
- Elsa R Flores$12,484,914
Others in their field
Other Emerging Leaders on “Signal Pathway”
- Mathangi Thiagarajan · Leidos Biomedical Research, Inc.$37,695,154
- Priyamvada Acharya · Duke University$20,941,151
- Maria C Carrillo · Indiana University Indianapolis$19,445,642
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$9,867,723
- Federico Cividini · Cardiac Rsk3 Inhibitors, Llc$9,716,114
- James Dale Berry · Brigham And Women'S Hospital$9,298,517
Research focus
Signal PathwayBaseMalignant NeoplasmsAreaOncogenicEventDrug TargetingMalignant Neoplasm Of LungPharmaceutical PreparationsTechnologyScientistCancer CenterBiological MarkersCancer PatientBiologyBackCollaborationsClinical SciencesClinical InvestigatorClinical TrialsCombined Modality TherapyBioimagingCancer Center Support GrantCell Survival
Grant awards (4)
Chemical Biology & Molecular Medicine$60,058
P30 · FY2021 · CA · contact PI
Race-related differential RNA splicing: novel targets for precision oncology in non-small cell lung cancer$377,130
R01 · FY2020 · CA
Chemical Biology & Molecular Medicine$60,062
P30 · FY2020 · CA · contact PI
Chemical Biology & Molecular Medicine$4,496
P30 · FY2020 · CA · contact PI